Market Overview

5 Biotech Secondaries Traders Are Watching

Share:
Related
Credit Suisse Says Gr3 Diarrhea Still A Concern For Puma Biotech, But Pullback Is Overdone
Puma Biotech Crashes After Bad News About Its Breast Cancer Drug
Puma Cancer Drug Suffers 'Approvability Risk' On Extreme Side Effect (Investor's Business Daily)
Related VSAR
15 Stocks Moving In Tuesday's Pre-Market Session
Stock Offerings En Vogue Over Last Several Sessions

Below are five biotech companies looking to raise money this week.

Puma Biotechnology Inc (NYSE: PBYI) is offering 1 million shares of stock. The underwriters are Bank of America Merrill Lynch, J.P. Morgan, Leerink Partners, and Cowen. The deal is expected to price Wednesday night and trade Thursday.

Versartis Inc (NASDAQ: VSAR) is offering $75 million of stock. The underwriters are Citigroup, Credit Suisse, Cowen, Canaccord Genuity, and SunTrust Robinson Humphrey. The deal is expected to price Wednesday night and trade Thursday.

Zafgen Inc (NASDAQ: ZFGN) is offering 2,840,909 shares of stock. The underwriters are Leerink, Cowen, Canaccord, and JMP Securities. The deal is expected to price Thursday night and trade Friday.

The company is expected to report Phase 3 results of Beloranib for Prader-Willi Syndrome in the fourth quarter.

Related Link: 10 Biotech Stories You Might've Missed

Vitae Pharmaceuticals Inc (NASDAQ: VTAE) is offering 3 million shares of stock. The underwriters are Stifel, BMO Capital, Piper Jaffray, JMP Securities, and Wedbush. The deal is expected to price Thursday night and trade Friday.

The company is expecting to report Phase 2 data of VTP-34072 for Type 2 diabetes in the first half of 2015.

Verastem Inc (NASDAQ: VSTM) is offering $40 million worth of stock. The underwriters are Jefferies, Leerink Partners, Guggenheim, and Oppenheimer. The deal is expected to price Thursday night and trade Friday.

Verastem is expected to announce an interim analysis for its Phase II trial of VS-6063 for mesothelioma in the second quarter.

Posted-In: Long Ideas Previews FDA Trading Ideas

 

Related Articles (PBYI + VSAR)

View Comments and Join the Discussion!